Strong performance to continue with >20% Q1e organic growth and estimates keep rising - '25e EBITA up 11%. Strong EPS growth to fuel more outperformance - keep BUY.
We trim '24e adj. EBITA by 4% on higher admin costs. Keep BUY: 42% EPS growth and cash conversion >100% in '24e. CMD thoughts: dividend policy and potential raised growth target?
Q4e: >20% organic growth remains, EBIT to double y-o-y. Sharp decline in USD/SEK partly offset by org. upgrades. Share to continue up in line with NTM earnings – BUY.
Dynavox once again impressed us, delivering accelerated volume growth from an already solid Q2 level to ~18% in Q3, which coupled with price increases of 7% adds up to an appealing 25% organic growth rate.
Q2e: strong volumes plus price hikes kicking in, 17% org. growth. We raise '24e-'25e adj. EBITA by 21-20% on FX and M&A. BUY stellar earnings growth and improving cash conversion.